Korea's SC Labs Targets GLP-1 Skin Sag with an Elastin-Fiber Booster

K-beauty is staking out a place in the Ozempic-face market. At in-cosmetics Global 2026 in Paris (April), Korean cosmetic lab SC Labs presented a blend dedicated to restoring elasticity in GLP-1 dieters. The pitch breaks with K-beauty’s last-decade pattern of leading with collagen-stimulating actives. The new target is something harder to engage: elastin fibers.

The launch

SC Labs’ new blend focuses on recovering skin elasticity lost during or after GLP-1 use. According to the company, the blend simultaneously promotes elastin and collagen synthesis to rebuild the skin’s recoil capacity.

The launch was reported in BeautyMatter’s in-cosmetics 2026 coverage. It was named alongside Italy’s Akott reishi adaptogen and Spain’s Provital hypodermis-remodeling active as the three most-noted GLP-1 face solutions at the show.

Why elastin

Skin elasticity comes from two proteins. Collagen handles tensile strength (resistance to pulling). Elastin handles recoil (the ability to stretch and snap back). The two are made by different fibroblast populations and degraded by different enzymes.

More than 90% of conventional anti-aging cosmetics target collagen. Peptides, retinol, vitamin C, growth factors all aim primarily at collagen synthesis. The reason is volume — collagen makes up about 80% of dermal protein. It is the largest single target.

The problem is that sagging after GLP-1 weight loss tracks elastin loss more than collagen loss. When subcutaneous fat deflates rapidly, the epidermis is stretched and then asked to retract. Elastin fibers, fatigued by repeated stretch and now bearing the recoil load alone, fail to return the skin to its previous length. The collagen scaffold is not torn — it has simply lost the volume it used to support.

Why elastin is hard

Elastin has long been a target the cosmetic industry has struggled to engage directly. New elastin synthesis is robust through puberty, then nearly stops by the mid-20s. Once made, an elastin fiber is essentially a lifetime protein — when it breaks down, it is rarely replaced.

Ingredients that can stimulate new elastin fiber assembly are scarce. Dipeptide-12, lysyl-oxidase activating peptides, and a handful of plant extracts (purified Centella asiatica fractions, Polygonatum extract) have shown elastin upregulation in vitro.

SC Labs has not publicly disclosed its exact composition, but a K-beauty R&D house putting elastin upfront is itself notable.

A shift in K-beauty positioning

The SC Labs case reads as a signal that K-beauty’s global positioning is changing.

The K-beauty wave of the last decade leaned on lifestyle-driven differentiation: fermented ingredients, multi-step routines, gentle textures. At this year’s in-cosmetics, Korean companies pivoted. They began presenting cosmetics not as a lifestyle category but as a technical solution to a drug-induced side effect.

GLP-1 happens to overlap with K-beauty’s strengths. Korea ranks high globally in pharmaceutical safety evaluation, peptide synthesis, and functional cosmetic certification. The MFDS functional-cosmetic regime requires more clinical evidence than the U.S. FDA’s OTC cosmetic classification. That infrastructure could give Korean players an edge in the new GLP-1 face functional category.

Implications for Korea’s market

GLP-1 adoption in Korea is slower than in the U.S. or Europe but unmistakably rising. Wegovy launched in 2024, and tirzepatide (Mounjaro) prescriptions began in 2026. Beyond obesity-clinic prescribing, a gray zone exists where physicians prescribe off-label for cosmetic weight goals.

SC Labs has not announced which finished-goods brands will license the blend. Even so, the signal that Korean R&D is aiming straight at this category matters. Within one or two years, K-beauty brands using labels like “GLP-1 care line” or “post-rapid-weight-loss recovery” are likely to surface.

A consumer note

When you encounter a product claiming elastin stimulation, two things are worth checking. First, whether the active list explicitly names dipeptide-12, lysyl-oxidase activating peptides, or a validated plant extract. Second, when “elastin fiber synthesis +X%” is shown on a label, whether the brand discloses if the figure comes from in vitro work or from human skin measurements.

Marketing copy that says only “elasticity booster” usually means a collagen stimulator. A product that distinguishes the two proteins is the more honest one.